Applications under the Production Linked Incentive (PLI) Scheme

PLI application for KSMs and APIs

Department of Pharmaceuticals had issued guidelines for the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country on 29th October 2020. Applications were invited under the Scheme which have already been appraised and selected.- PLI application for KSMs and APIs-PLI in food processing

The Department further invites applications from eligible applicants under the Scheme
for the left over slots/quantity for the following eligible products:-

Target Segment	Name of Eligible Product	Minimum Annual Production Capacity as per Scheme Guidelines (in MT)	Shortfall in Minimum Annual Production Capacity (in MT)	Maximum no. of applicants to be selected
Key Fermentation based KSMs/Drug Intermediates	Erythromycin Thiocynate (TIOC)	800	1,600 MT	2
	7 – ACA	1000	1,000 MT	1
Fermentation based niche KSMs/Drug Intermediates /APIs	Neomycin	80	160 MT	2
	Gentamycin	40	80 MT	2
	Vitamin B1	200	200 MT	1
	Clindamycin Bas	60	120 MT	2
	Streptomycin	50	100 MT	2
	Tetracycline	200	400 MT	2
Key Chemical Synthesis based KSMs/Drug Intermediates	Dicyandiamide (DCDA)	8000	32,000 MT	4
	2-MNI	800	3200 MT	4

The last date for filing of the application is 45 days from the issuance of the Notice.